Omepral® Tablets Special Clinical Experience Investigation in Patients With Erosive Esophagitis

NCT00859287 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 10703

Last updated 2009-07-15

No results posted yet for this study

Summary

This open label, non-interventional study is to compare the efficacy of Omepral® tablet and any other treatments excepting proton pump inhibitors (PPIs) for the treatment of various type of acid reflux related symptoms in patients with reflux esophagitis.

Conditions

  • Reflux Esophagitis

Sponsors & Collaborators

Principal Investigators

  • AstraZeneca Japan Medical Director MD · AstraZeneca

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-06-30
Completion
2008-07-31

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00859287 on ClinicalTrials.gov